Search

Suzanne Marie Noakes

Examiner (ID: 17824)

Most Active Art Unit
1656
Art Unit(s)
1656, 1653
Total Applications
1691
Issued Applications
1090
Pending Applications
193
Abandoned Applications
452

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20059615 [patent_doc_number] => 20250197837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/069321 [patent_app_country] => US [patent_app_date] => 2025-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19069321 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/069321
SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF Mar 3, 2025 Pending
Array ( [id] => 20121816 [patent_doc_number] => 20250236847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-24 [patent_title] => COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION [patent_app_type] => utility [patent_app_number] => 19/060404 [patent_app_country] => US [patent_app_date] => 2025-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19060404 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/060404
COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION Feb 20, 2025 Pending
Array ( [id] => 19877138 [patent_doc_number] => 20250109395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME [patent_app_type] => utility [patent_app_number] => 18/970552 [patent_app_country] => US [patent_app_date] => 2024-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18970552 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/970552
S. pyogenes CAS9 mutant genes and polypeptides encoded by same Dec 4, 2024 Issued
Array ( [id] => 19855764 [patent_doc_number] => 12258588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-25 [patent_title] => Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/919946 [patent_app_country] => US [patent_app_date] => 2024-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 9 [patent_no_of_words] => 13318 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919946 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/919946
Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof Oct 17, 2024 Issued
Array ( [id] => 19877133 [patent_doc_number] => 20250109390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => COMPOSITIONS FOR PREVENTING OR TREATING CORONAVIRUS INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/914016 [patent_app_country] => US [patent_app_date] => 2024-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68448 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18914016 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/914016
Compositions for preventing or treating coronavirus infections Oct 10, 2024 Issued
Array ( [id] => 19809737 [patent_doc_number] => 12241109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Host cells comprising a recombinant casein protein and a recombinant kinase protein [patent_app_type] => utility [patent_app_number] => 18/886925 [patent_app_country] => US [patent_app_date] => 2024-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 43 [patent_no_of_words] => 90167 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886925 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/886925
Host cells comprising a recombinant casein protein and a recombinant kinase protein Sep 15, 2024 Issued
Array ( [id] => 19682411 [patent_doc_number] => 20250000956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => RECOMBINANT CELL WALL HYDROLASES [patent_app_type] => utility [patent_app_number] => 18/882318 [patent_app_country] => US [patent_app_date] => 2024-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882318 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/882318
Recombinant cell wall hydrolases Sep 10, 2024 Issued
Array ( [id] => 19631460 [patent_doc_number] => 20240409909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => ALPHA-AMYLASE VARIANTS [patent_app_type] => utility [patent_app_number] => 18/774233 [patent_app_country] => US [patent_app_date] => 2024-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774233 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/774233
ALPHA-AMYLASE VARIANTS Jul 15, 2024 Pending
Array ( [id] => 19746032 [patent_doc_number] => 20250034597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci [patent_app_type] => utility [patent_app_number] => 18/764634 [patent_app_country] => US [patent_app_date] => 2024-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11128 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18764634 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/764634
RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci Jul 4, 2024 Pending
Array ( [id] => 19631432 [patent_doc_number] => 20240409881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => METHOD FOR EXPANDING PROPAGATION OF METARHIZIUM RILEYI MR006 AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/734239 [patent_app_country] => US [patent_app_date] => 2024-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4042 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18734239 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/734239
Method for expanding propagation of Jun 4, 2024 Issued
Array ( [id] => 19528538 [patent_doc_number] => 20240352440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => ENZYMATIC PRODUCTION OF HEXOSES [patent_app_type] => utility [patent_app_number] => 18/641530 [patent_app_country] => US [patent_app_date] => 2024-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641530 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/641530
ENZYMATIC PRODUCTION OF HEXOSES Apr 21, 2024 Pending
Array ( [id] => 19528538 [patent_doc_number] => 20240352440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => ENZYMATIC PRODUCTION OF HEXOSES [patent_app_type] => utility [patent_app_number] => 18/641530 [patent_app_country] => US [patent_app_date] => 2024-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36251 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641530 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/641530
ENZYMATIC PRODUCTION OF HEXOSES Apr 21, 2024 Pending
Array ( [id] => 19345553 [patent_doc_number] => 20240254516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => COMPLEX FOR GENOME EDITING HAVING STABILITY AND FEW SIDE-EFFECTS, AND NUCLEIC ACID CODING SAME [patent_app_type] => utility [patent_app_number] => 18/634640 [patent_app_country] => US [patent_app_date] => 2024-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19035 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18634640 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/634640
COMPLEX FOR GENOME EDITING HAVING STABILITY AND FEW SIDE-EFFECTS, AND NUCLEIC ACID CODING SAME Apr 11, 2024 Pending
Array ( [id] => 19474011 [patent_doc_number] => 12104088 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-10-01 [patent_title] => Bone gelatin process [patent_app_type] => utility [patent_app_number] => 18/614665 [patent_app_country] => US [patent_app_date] => 2024-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2658 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 302 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18614665 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/614665
Bone gelatin process Mar 22, 2024 Issued
Array ( [id] => 19770315 [patent_doc_number] => 20250051741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => OMNI-103 CRISPR NUCLEASE [patent_app_type] => utility [patent_app_number] => 18/613508 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613508 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/613508
OMNI-103 CRISPR NUCLEASE Mar 21, 2024 Pending
Array ( [id] => 19770315 [patent_doc_number] => 20250051741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => OMNI-103 CRISPR NUCLEASE [patent_app_type] => utility [patent_app_number] => 18/613508 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613508 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/613508
OMNI-103 CRISPR NUCLEASE Mar 21, 2024 Pending
Array ( [id] => 19404056 [patent_doc_number] => 20240287567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => ENZYMATIC METHOD FOR PREPARING REBAUDIOSIDE J [patent_app_type] => utility [patent_app_number] => 18/600332 [patent_app_country] => US [patent_app_date] => 2024-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600332 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/600332
ENZYMATIC METHOD FOR PREPARING REBAUDIOSIDE J Mar 7, 2024 Abandoned
Array ( [id] => 19249060 [patent_doc_number] => 20240200047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-20 [patent_title] => ENZYMES WITH RUVC DOMAINS [patent_app_type] => utility [patent_app_number] => 18/586929 [patent_app_country] => US [patent_app_date] => 2024-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56338 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18586929 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/586929
Enzymes with RUVC domains Feb 25, 2024 Issued
Array ( [id] => 19389761 [patent_doc_number] => 20240279631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => Chimeric endolysin polypeptide [patent_app_type] => utility [patent_app_number] => 18/582803 [patent_app_country] => US [patent_app_date] => 2024-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9544 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582803 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/582803
Chimeric endolysin polypeptide Feb 20, 2024 Issued
Array ( [id] => 19361148 [patent_doc_number] => 20240263182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => METHODS AND MICROORGANISMS FOR MAKING 2,3-BUTANEDIOL AND DERIVATIVES THEREOF FROM C1 CARBONS [patent_app_type] => utility [patent_app_number] => 18/582362 [patent_app_country] => US [patent_app_date] => 2024-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582362 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/582362
METHODS AND MICROORGANISMS FOR MAKING 2,3-BUTANEDIOL AND DERIVATIVES THEREOF FROM C1 CARBONS Feb 19, 2024 Pending
Menu